Animal Model Market Size By Animal Type (Mice, Rats, Fish, Birds, Cattles, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Applications (Research & Development {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal disease, Diabetic eye disease, Fibrosis, Microbiome}, Production and Quality Control, Academics, Preclinical Applications {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal disease, Diabetic eye disease, Fibrosis, Microbiome}), By Use (Human and Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organisations {Government, Non-government}, Academic and Research Institutes, Contract Research Organizations (CRO)), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Nov 2020  |  Report ID: GMI4435  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 596   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Animal Model Market size exceeded USD 14.9 billion in 2019 and is expected to achieve over 7.5% CAGR from 2020 to 2026. Growing prevalence of chronic diseases and increase in adverse effects of drugs has positively impacted the market growth. Increasing use of advanced technologies such as microinjection and CRISPR-Cas9 have benefitted biomedical researchers and scientists engaged in research studies, leading to increased adoption of animals.
 

Rapidly growing demand for personalized medicines has led to an increase in development of humanized mouse models. Initiatives by government organizations in various academic and research institutions have led to increased awareness pertaining to the use of animal models.
 

Animal Model Market
Get more details on this report - Request Free Sample PDF
 

The ongoing COVID-19 pandemic is an unprecedented public health concern and has led to an increase in research & development of vaccines as well as antiviral drugs. Therefore, animals are needed in large numbers to verify the efficacy and safety before the conducting human trials of the vaccines and antiviral drugs. The demand for humanized ACE2 mouse models, that develops a lethal SARS-CoV infection is increasing owing to the need to conduct research experiments. Government and scientific research institutions are bound to increase research investments to develop vaccines and treatments against COVID-19.
 

Several companies are also working on various animal to develop a vaccine or drug against COVID-19. However, several research institutions are unable to operate normally and some of the market players are unable to meet the surging demand due to the ongoing pandemic that has adversely affected the animal model market value.
 

Growing demand for personalized medicine will enhance the animal model market demand

Increasing consumption of personalized medicine has augmented the demand for humanized mouse models for treatment of certain disorders such as Alzheimer’s and Amyotrophic Lateral Sclerosis. According to a recently published study by the National Institute of Aging, humanized mouse model allows precision medicine research for psychological disorders including Alzheimer’s disease. The study revealed that most of the molecular features of Alzheimer’s disease can be replicated in a humanized mouse model that further increases the research for precision medicine with respect to Alzheimer’s disease.
 

Rising preference for mice models

The mice model market valued more than USD 7.6 billion in 2019 propelled by the factors such as physiological similarities and phylogenetic relatedness of mice to the humans coupled with their ease of maintenance and breeding in the laboratory. The genome of mice can be manipulated and analysed easily, making them an ideal choice for genetic research studies such as immunology and inflammation studies, oncology studies, central nervous system studies, and diabetes studies. This led to an increased adoption and demand for mice models by the researchers.
 

Increasing adoption of CRISPR technology will foster the market size

The CRISPR segment in the animal model market is expected to witness around 8% growth rate through 2026 led by the reduction in cost and time needed for genome editing and enabling the production of animal models with genetic modifications. CRISPR technology is also used to produce animal to study human disease progression in a controlled manner and to evaluate potential therapies.
 

Growing need for production and quality control for therapeutic purpose

The animal model market for production and quality control application valued at USD 2.2 billion in 2019 impelled by the increased demand for animal to test the safety of vaccines such as tuberculosis and malaria vaccine. According to the National Center for Biotechnology Information (NCBI), approximately 15% of the total animal models are used for the vaccine production and quality control. The high demand for targeted therapy and personalized medicine to treat cancer patients has also led to higher production and quality control check.
 

Rise in demand for disease treatment in humans will spur the animal model market share

Human segment revenue crossed USD 12 billion in 2019 driven by the factors such as increasing focus towards studying human-specific infections, immune responses and therapies along with identification of the actual effect of drugs on humans. Animal models are fundamental in clinical research for determining the pharmacodynamic and pharmacokinetics of the drugs used in the treatment of human diseases.
 

The demand for animal models is significantly increasing in human-related disease conditions. Furthermore, the rising prevalence of cancer, infectious diseases, HIV/AIDS and hepatitis has augmented the adoption of animal models for biomedical research of these diseases.
 

Increased demand of animal models by academic and research institutions

Animal Model Market Size

Get more details on this report - Request Free Sample PDF
 

 The academic and research institutions end-use segment in the animal model market valued more than USD 293 million in 2019 due to the growing preference of animal models for research experiments in academic and research institutions. The academic and research institutions use the preserved animal models to study and understand the behaviour of drug toxicity. These institutions also use animal models to teach laboratory animal science to the students.
 

Rise in demand for animal models in the European market

  Animal Model Market Share

Get more details on this report - Request Free Sample PDF
 

UK animal model market accounted for USD 648 million in 2019. Animals in UK are being used on a large scale for research and development of novel vaccines. The European Association for Cancer Research is organizing workshops in the country to discuss the technologies developed in the field of innovative mouse models. This initiative has the potential to expand the market in the country.
 

In the UK, the search for better animals for treatment of Alzheimer’s disease has influenced the demand for animal models. The European Union is also engaged in sponsoring research organization consortiums for R&D on mouse models for Alzheimer’s disease.
 

Japan dominated the in Asia Pacific market size with around USD 1.19 billion revenue in 2019 on account of the increase in research on biomedical, regenerative medicine, and rising medical research in the country. Large geriatric patient population pool suffering from chronic diseases requiring extensive prevention and treatment has led to increased demand for animal models. Government funding in Japan has also led to advancements in biological research, thereby augmenting the adoption and demand for animals. Moreover, presence of well-established research laboratories and healthcare institutes is one of the major driving factors propelling the demand for animal in the country.
 

Presence of strong key players implementing strategic initiatives will contribute to the market revenue

Some of the major participants operating in the animal model market include Charles River, Envigo, genOway, Harbour BioMed, Janvier Labs, Horizon Discovery Group plc, The Jackson Laboratory and Taconic Biosciences Inc. These companies are focussing towards strategic acquisitions, mergers, collaborations and partnerships in order to expand customer base and strengthen their industrial position. The investment by these players in recent years has created opportunities of global expansion for the market.
 

Recent industry developments:

  • In April 2019, Envigo announced to acquire Covance Research Products business through its research model services business, thereby solely focusing on research models and services. This strategic acquisition assisted the company to expand their market share and strengthening their industrial position.
     
  • In March 2019, Charles River announced a licensing collaboration with Crown Bioscience for expanding access to Zucker Diabetic Sprague-Dawley (ZDSD) rat model through its breeding and distribution. This strategic move assisted the company in enhancing their product portfolio and industrial position.
     

This market research report on animal model includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

Market, By Animal Type 2015 - 2026 (USD Million and Units)

  • Mice
  • Rats
  • Fish
  • Birds
  • Cattles
  • Pigs
  • Amphibians
  • Guinea Pigs
  • Dogs
  • Cats
  • Rabbits
  • Monkeys
  • Sheep
  • Hamsters
  • Others

Market, By Technology, 2015 - 2026 (USD Million)

  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Others

Market, By Application, 2015 - 2026 (USD Million)

  • Research & Development 
  • Infectious Disease
  • Immunological Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Genetic Diseases
  • Neurological Diseases
  • Obesity
  • NAFLD/NASH
  • Renal disease
  • Diabetic eye disease
  • Fibrosis
  • Microbiome
  • Others
  • Production and Quality Control
  • Academics
  • Preclinical Applications 
  • Infectious Disease
  • Immunological Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Genetic Diseases
  • Neurological Diseases
  • Obesity
  • NAFLD/NASH
  • Renal disease
  • Diabetic eye disease
  • Fibrosis
  • Microbiome
  • Others
  • Others

Market, By Use, 2015 - 2026 (USD Million)

  • Human
  • Veterinary

Market, By End-use, 2015 - 2026 (USD Million)

  • Companies
  • Pharmaceutical
  • Biotechnology
  • Cosmetics
  • Others
  • Organizations 
  • Government
  • Non-government
  • Academic and Research Institutes
  • Contract Research Organizations (CRO)

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Switzerland
    • Netherlands
    • Czech Republic
    • Poland
    • Belgium
    • Finland
    • Hungary
    • Denmark
    • Ireland
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • New Zealand
    • Taiwan
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel

 

Frequently Asked Questions (FAQ) :

The global animal model industry revenue surpassed USD 14.9 billion in 2019 and is estimated to grow over 7.5% CAGR through 2026.
The CRISPR animal model industry size is poised to grow at about an 8% rate through 2026 owing to the decrease in cost and time required for genome editing.
In 2019, the academic and research institutions segment valued at over USD 293 million in 2019 and is expected to witness substantial growth due to the increasing preference of animal models for research experiments in the segment.
The UK animal model industry size valued at USD 648 million in 2019 and the usage of animals on a large scale for research and development of novel vaccines will boost regional growth.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Premium Report Details

  • Published Date: Nov 2020
  • Pages: 596
  • Tables: 902
  • Charts / Figures: 20
  • Companies covered: 9
  • Countries covered: 30

Get a report that explains COVID-19 impact on this market, request a free sample now

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X